FDA hits Chinese OTC drugmaker with warning letter over data, testing issues
admin 7th March 2018 Uncategorised 0The FDA issued a warning letter to Chinese OTC drugmaker Zhejiang Ludao Technology, citing data integrity and product testing issues.
More: FDA hits Chinese OTC drugmaker with warning letter over data, testing issues
Source: fierce